Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Clinical Trials (London, England)|May 21, 2025
Sequential monitoring of time-to-event safety endpoints in clinical trialsMichael J Martens, Qinghua Lian, Nancy L Geller, et al.
Clinical Trials (London, England)|August 10, 2010
Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trialJungnam Joo, Nancy L Geller, Benjamin French, et al.
BMC Proceedings|May 10, 2008
Robust ranks of true associations in genome-wide case-control association studiesGang Zheng, Jungnam Joo, Jing-Ping Lin, et al.
Statistics in Medicine|June 27, 2012
NHLBI clinical trials workshop: an executive summaryGang Zheng, Colin O Wu, Song Yang, et al.
Biomed Research International|September 9, 2015
Robust Association Tests for the Replication of Genome-Wide Association StudiesJungnam Joo, Ju-Hyun Park, Bora Lee, et al.
Trials|November 19, 2010
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trialBenjamin French, Jungnam Joo, Nancy L Geller, et al.
European Heart Journal|February 5, 2008
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definitionFaiez Zannad, Wendy Gattis Stough, Bertram Pitt, et al.
Clinical Trials (London, England)|May 18, 2024
Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical TrialJungnam Joo, Eric S Leifer, Michael A Proschan, et al.
Haematologica|November 16, 2016
Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trialJeremy Pantin, Enkhtsetseg Purev, Xin Tian, et al.
The New England Journal of Medicine|November 9, 2004
Angiotensin-converting-enzyme inhibition in stable coronary artery diseaseEugene Braunwald, Michael J Domanski, Sarah E Fowler, et al.
Pageof 5